Lloyd J. Old STAR Program with a Grant for Cancer Immunology Researchers by CRI

Cancer Research Institute (CRI) is offering the Lloyd J. Old STAR Program for researchers in cancer immunology all over the world. The Lloyd J. Old STAR Program provides grants of $1.25 million over 5 years to mid-career scientists.

About the Program:

The Lloyd J. Old STAR Program is a long-term funding which is not tied to a specific research project, but rather aims to provide a degree of flexibility and freedom for investigators to explore out-of-the-box and disruptive avenues of research. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology.

• Lloyd J. Old STAR Program grants provide up to $250,000 per year for five years. 
• Awarded funds are intended to be flexible and may be used for salary, technical assistance, supplies, capital equipment, or scientific travel. 
• CRI does not provide funds for indirect costs. 
• Payments are made quarterly in U.S. currency to the host institution.

• Candidates for the Lloyd J. Old STAR program must meet the following eligibility requirements:
• The applicant must have an M.D., Ph.D., or M.D./Ph.D. (or equivalent)
• Applicants must belong to one of the following categories as of July 1, 2021:
• Tenure-track assistant professor with a minimum of 3 years in this position (appointed on or before July 1, 2018)
• Tenure-track associate professor with a maximum of 3 years in this position (appointed on or after July 1, 2018)
• Adjunct or acting positions are not eligible.
• Applicants are expected to commit a minimum of 80% of their time to conducting research.
• CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. 
• The Cancer Research Institute does not support research at for-profit institutions.

About CRI:

The Cancer Research Institute is (CRI) a nonprofit organization dedicated to harnessing the human's immune system's power to control and potentially cure all types of cancer. (CRI) funds the most innovative clinical and laboratory research around the world, supports the next generation of the field's leaders, and serves as the trusted source of information on immunotherapy for cancer patients and their caregivers. CRI Works in tandem with its global network of researchers, supporters, patients, and advocates while promoting awareness, sharing up-to-date immunotherapy information, and inspiring lifelong advocacy for the cause.

See more available bachelor scholarships on For9a

See more available competition and awards on For9a